327 related articles for article (PubMed ID: 23864287)
1. In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.
Blázquez L; Aiastui A; Goicoechea M; Martins de Araujo M; Avril A; Beley C; García L; Valcárcel J; Fortes P; López de Munain A
Hum Mutat; 2013 Oct; 34(10):1387-95. PubMed ID: 23864287
[TBL] [Abstract][Full Text] [Related]
2. CAPN3 mRNA processing alteration caused by splicing mutation associated with novel genomic rearrangement of Alu elements.
Salem IH; Hsairi I; Mezghani N; Kenoun H; Triki C; Fakhfakh F
J Hum Genet; 2012 Feb; 57(2):92-100. PubMed ID: 22158424
[TBL] [Abstract][Full Text] [Related]
3. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.
Blázquez L; Azpitarte M; Sáenz A; Goicoechea M; Otaegui D; Ferrer X; Illa I; Gutierrez-Rivas E; Vilchez JJ; López de Munain A
Neurogenetics; 2008 Jul; 9(3):173-82. PubMed ID: 18563459
[TBL] [Abstract][Full Text] [Related]
5. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.
Dominov JA; Uyan Ö; McKenna-Yasek D; Nallamilli BRR; Kergourlay V; Bartoli M; Levy N; Hudson J; Evangelista T; Lochmuller H; Krahn M; Rufibach L; Hegde M; Brown RH
Ann Clin Transl Neurol; 2019 Apr; 6(4):642-654. PubMed ID: 31019989
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional explorations of CAPN3 identify novel splicing mutations, a large-sized genomic deletion and evidence for messenger RNA decay.
Krahn M; Pécheux C; Chapon F; Béroud C; Drouin-Garraud V; Laforet P; Romero NB; Penisson-Besnier I; Bernard R; Urtizberea JA; Leturcq F; Lévy N
Clin Genet; 2007 Dec; 72(6):582-92. PubMed ID: 17979987
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.
Hu Y; Mohassel P; Donkervoort S; Yun P; Bolduc V; Ezzo D; Dastgir J; Marshall JL; Lek M; MacArthur DG; Foley AR; Bönnemann CG
J Neuromuscul Dis; 2019; 6(4):475-483. PubMed ID: 31498126
[TBL] [Abstract][Full Text] [Related]
8. Entire CAPN3 gene deletion in a patient with limb-girdle muscular dystrophy type 2A.
Jaka O; Azpitarte M; Paisán-Ruiz C; Zulaika M; Casas-Fraile L; Sanz R; Trevisiol N; Levy N; Bartoli M; Krahn M; López de Munain A; Sáenz A
Muscle Nerve; 2014 Sep; 50(3):448-53. PubMed ID: 24715573
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide treatment for a pseudoexon-generating mutation in the NPC1 gene causing Niemann-Pick type C disease.
Rodríguez-Pascau L; Coll MJ; Vilageliu L; Grinberg D
Hum Mutat; 2009 Nov; 30(11):E993-E1001. PubMed ID: 19718781
[TBL] [Abstract][Full Text] [Related]
10. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; Urtasun M; Vílchez J; Gutiérrez-Rivas E; Emparanza J; Merlini L; Paisán C; Goicoechea M; Blázquez L; Eymard B; Lochmuller H; Walter M; Bonnemann C; Figarella-Branger D; Kaplan JC; Urtizberea JA; Martí-Massó JF; López de Munain A
Brain; 2005 Apr; 128(Pt 4):732-42. PubMed ID: 15689361
[TBL] [Abstract][Full Text] [Related]
11. Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy.
Shin JH; Kim HS; Lee CH; Kim CM; Park KH; Kim DS
J Korean Med Sci; 2007 Jun; 22(3):463-9. PubMed ID: 17596655
[TBL] [Abstract][Full Text] [Related]
12. Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping.
Wein N; Avril A; Bartoli M; Beley C; Chaouch S; Laforêt P; Behin A; Butler-Browne G; Mouly V; Krahn M; Garcia L; Lévy N
Hum Mutat; 2010 Feb; 31(2):136-42. PubMed ID: 19953532
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide induced pseudoexon skipping and restoration of functional protein for Fukuyama muscular dystrophy caused by a deep-intronic variant.
Enkhjargal S; Sugahara K; Khaledian B; Nagasaka M; Inagaki H; Kurahashi H; Koshimizu H; Toda T; Taniguchi-Ikeda M
Hum Mol Genet; 2023 Apr; 32(8):1301-1312. PubMed ID: 36426838
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of CAPN3 transcripts in LGMD2A patients: involvement of nonsense-mediated mRNA decay.
Stehlíková K; Zapletalová E; Sedlácková J; Hermanová M; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Vohánka S; Fajkus J; Fajkusová L
Neuromuscul Disord; 2007 Feb; 17(2):143-7. PubMed ID: 17157502
[TBL] [Abstract][Full Text] [Related]
15. Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies.
Hadj Salem I; Kamoun F; Louhichi N; Rouis S; Mziou M; Fendri-Kriaa N; Makni-Ayadi F; Triki C; Fakhfakh F
Biosci Rep; 2011 Apr; 31(2):125-35. PubMed ID: 20477750
[TBL] [Abstract][Full Text] [Related]
16. cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.
Duno M; Sveen ML; Schwartz M; Vissing J
Eur J Hum Genet; 2008 Aug; 16(8):935-40. PubMed ID: 18337726
[TBL] [Abstract][Full Text] [Related]
17. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3.
Jenne DE; Kley RA; Vorgerd M; Schröder JM; Weis J; Reimann H; Albrecht B; Nürnberg P; Thiele H; Müller CR; Meng G; Witt CC; Labeit S
Biol Chem; 2005 Jan; 386(1):61-7. PubMed ID: 15843148
[TBL] [Abstract][Full Text] [Related]
18. Mutational Spectrum of CAPN3 with Genotype-Phenotype Correlations in Limb Girdle Muscular Dystrophy Type 2A/R1 (LGMD2A/LGMDR1) Patients in India.
Pathak P; Sharma MC; Jha P; Sarkar C; Faruq M; Jha P; Suri V; Bhatia R; Singh S; Gulati S; Husain M
J Neuromuscul Dis; 2021; 8(1):125-136. PubMed ID: 33337384
[TBL] [Abstract][Full Text] [Related]
19. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
20. Limb-Girdle Muscular Dystrophy Type 2A Resulting From c.C479G and c.G1818A Mutations in the Calpain-3 Gene.
Ramos E; Pardo S; Mas Rodríguez MF; Vélez J
J Clin Neuromuscul Dis; 2015 Dec; 17(2):59-62. PubMed ID: 26583491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
